Eliot Ward - January 2, 2026 MiRXES Case Study Mewburn Ellis advised MiRXES on the full IP workstream for its complex HKEx IPO, delivering the due ... Read more
Thomas Wolter - April 1, 2025 Bristol Myers Squibb Case Study Following the EPO’s revocation of the basic dasatinib patent, we had assisted Bristol Myers Squibb ...
.png)